发现 帖子

在我们的“发现”页面上探索迷人的内容和多样化的观点。发现新想法并参与有意义的对话

ethantaylor 创建了一篇新文章
5 周

Top 10 Conference Coverage Companies Helping Pharma Stay Ahead of Competitors | #confrence coverage

Top 10 Conference Coverage Companies Helping Pharma Stay Ahead of Competitors

Top 10 Conference Coverage Companies Helping Pharma Stay Ahead of Competitors

Top 10 Conference Coverage Companies Helping Pharma Stay Ahead of Competitors
ethantaylor 创建了一篇新文章
5 周

Top 10 Conference Coverage Companies for Regulatory & Policy-Focused Events | #confrence coverage

Top 10 Conference Coverage Companies for Regulatory & Policy-Focused Events

Top 10 Conference Coverage Companies for Regulatory & Policy-Focused Events

Top 10 Conference Coverage Companies for Regulatory & Policy-Focused Events
k kumar 创建了一篇新文章
5 周

DelveInsightの推定によると、7MMの妊娠中毒症治療薬市場は2024年に約8,000万米ドルに達し、2034年までに拡大すると予測されています。 | #healthcare

DelveInsightの推定によると、7MMの妊娠中毒症治療薬市場は2024年に約8,000万米ドルに達し、2034年までに拡大すると予測されています。

DelveInsightの推定によると、7MMの妊娠中毒症治療薬市場は2024年に約8,000万米ドルに達し、2034年までに拡大すると予測されています。

DelveInsightの「妊娠中毒症市場の洞察、疫学、市場予測 - 2034年」レポートは、妊娠中毒症の疫学、市場動向、そして臨床的進歩に関する包括的なレビューを提供しています。本レポートには、過去および予測の疫学デ
johnsnow 创建了一篇新文章
5 周

Vascular Grafts: Clinical Progress, Technology Shifts, and Market Evolution | #health

Vascular Grafts: Clinical Progress, Technology Shifts, and Market Evolution

Vascular Grafts: Clinical Progress, Technology Shifts, and Market Evolution

Vascular Grafts: Clinical Progress, Technology Shifts, and Market Evolution
ethantaylor 创建了一篇新文章
5 周

Top 10 Conference Coverage Companies for Rare Disease & Orphan Drug Events | #confrence coverage

Top 10 Conference Coverage Companies for Rare Disease & Orphan Drug Events

Top 10 Conference Coverage Companies for Rare Disease & Orphan Drug Events

Top 10 Conference Coverage Companies for Rare Disease & Orphan Drug Events
ethantaylor 创建了一篇新文章
5 周

Top 10 Conference Coverage Companies for Pipeline & Clinical Trial Tracking | #confrence coverage

Top 10 Conference Coverage Companies for Pipeline & Clinical Trial Tracking

Top 10 Conference Coverage Companies for Pipeline & Clinical Trial Tracking

Top 10 Conference Coverage Companies for Pipeline & Clinical Trial Tracking
k kumar 创建了一篇新文章
5 周

多系統萎縮症のパイプラインは力強い勢いを示し、20社以上の主要製薬企業が治療薬開発を牽引 | DelveInsight | #healthcare

多系統萎縮症のパイプラインは力強い勢いを示し、20社以上の主要製薬企業が治療薬開発を牽引 | DelveInsight

多系統萎縮症のパイプラインは力強い勢いを示し、20社以上の主要製薬企業が治療薬開発を牽引 | DelveInsight

DelveInsightの最新レポート「多系統萎縮症パイプラインの洞察、2025年」は、多系統萎縮症(MSA)のパイプラ
ethantaylor 创建了一篇新文章
5 周

Essential Thrombocythemia Market Poised for Significant Growth Throughout the Forecast Period (2020-2034) | DelveInsight | #essential Thrombocythemia (ET) market # Essential Thrombocythemia (ET) market research # Essential Thrombocythemia (ET) market insight # Essential Thrombocythemia (ET) market trends

Essential Thrombocythemia Market Poised for Significant Growth Throughout the Forecast Period (2020-2034) | DelveInsight

Essential Thrombocythemia Market Poised for Significant Growth Throughout the Forecast Period (2020-2034) | DelveInsight

Essential Thrombocythemia Market Poised for Significant Growth Throughout the Forecast Period (2020-2034) | DelveInsight
k kumar 创建了一篇新文章
5 周

Global Artificial Cornea and Corneal Implant Market Size, Share, and Outlook to 2030 | #healthcare

Global Artificial Cornea and Corneal Implant Market Size, Share, and Outlook to 2030

Modern ophthalmology is experiencing a transformative shift as breakthrough technologies address the pressing challenge of corneal blindness and vision impairment
k kumar 创建了一篇新文章
5 周

The Science Driving Better Outcomes in Type 2 Diabetes | #healthcare

The Science Driving Better Outcomes in Type 2 Diabetes

The Science Driving Better Outcomes in Type 2 Diabetes

As treatment paradigms continue to advance, maintaining awareness of therapeutic developments and revolutionary care options proves vital for both medical professionals and individuals managing this lifelong condition